Structure Therapeutics ( NASDAQ: GPCR ) announced the pricing of its upsized underwritten public offering of 9,066,972 ADSs from the previous offering, each representing three ordinary shares, at a public offering price of $52.50 per ADS. The gross proceeds from the offering are expected to be approximately $476.
0 million. In addition, GPCR has granted the underwriters a 30-day option to purchase up to an additional 1,360,045 ADSs at the public offering price. The offering is expected to close on or about June 7, 2024.
More on Structure Therapeutics Structure Therapeutics' Slim Obesity Hopes In A Pill Take Shape Structure Therapeutics announces proposed public offering of American depositary shares and pre-funded warrants Structure Therapeutics rises after obesity treatment study meets main and secondary goals Seeking Alpha’s Quant Rating on Structure Therapeutics Historical earnings data for Structure Therapeutics.
